Back to results
US 2021/0268101 A1Published application
NOVEL PEPTIDES FOR VACCINATION AND TREATMENT OF 2019-nCoV INFECTIONS
AssigneeCel-Sci Corporation
InventorDaniel H. Zimmerman
Life of this patent
Estimating the term…
Abstract
The invention relates to novel peptide immunoconjugates for treatment, prevention, and diagnosis of coronaviral infections in animals and humans. The immunoconjugates can be used alone or in conjunction with vaccine adjuvants, immune system cells, or other immunomodulators.
Claims19
A peptide heteroconjugate, comprising:
- a peptide of SEQ ID NO's:
- 1-6 or 13-15 conjugated to an immunomodulatory peptide by a direct bond or a divalent linking group.
A composition, comprising:
- at least one peptide heteroconjugate selected from the group consisting of:
- SEQ ID NO 9, SEQ ID NO 10, SEQ ID NO 11, SEQ ID NO 12, SEQ ID NO 16, SEQ ID NO 17, SEQ ID NO 18, SEQ ID NO 19, SEQ ID NO 20, and SEQ ID NO 21;
- and
- an adjuvant.
1 more element
Dependencies are inferred from the claim text.